Bioidentical vs Synthetic Hormone Therapy for Menopausal Women: Which Option is Safer? episode artwork

EPISODE · Sep 24, 2016 · 17 MIN

Bioidentical vs Synthetic Hormone Therapy for Menopausal Women: Which Option is Safer?

from Clinician's Roundtable

Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG Many menopausal and perimenopausal women are faced with the decision of whether synthetic or bioidentical hormone therapy is the best option for them. There are many pros and cons for each, but questions surface from patients and clinicians alike on comparative safety and efficacy profiles. Host Dr. Renee Allen welcomes Dr. Jocelyn Slaughter-Moore, a board-certified practicing OB/GYN at Heras Healthcare for Women. They talk about the differences between bioidentical and synthetic hormones, and whether bioidentical hormone therapy is a safe option for women.

Episode metadata supplied by the publisher feed · Published Sep 24, 2016

Embed this episode

NOW PLAYING

Bioidentical vs Synthetic Hormone Therapy for Menopausal Women: Which Option is Safer?

0:00 17:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Clinician's Roundtable?

This episode is 17 minutes long.

When was this Clinician's Roundtable episode published?

This episode was published on September 24, 2016.

Can I download this Clinician's Roundtable episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!